Category Specific RSS

News

Direct marketing of biotags and global expansion mark BlueChiip’s cheery entry into FY24

A blue chip denotes the cream of the crop—the most put-together, high-quality company or share. So one can only imagine…

3 years ago

Atturra shoots for regional expansion, acquires Newcastle-based IT company for $5 million

Advisory and tech services company Atturra (ASX: ATA) is making headway into regional Australia, with its subsidiary Atturra Holdings acquiring…

3 years ago

Vmoto gears up for EV boom, sets up new manufacturing facilities to increase production capacity

In the Asian market, electric vehicles are set to see massive growth, with revenue projected to reach $671 billion by…

3 years ago

After 4 year certification process, Elsight partner Airobotics secures regulatory clearance to operate its drones above people

If you’ve ever had fears about being knocked out by a drone falling out of the sky, rest assured there…

3 years ago

Carnegie Clean Energy wins $6.3 million EuropeWave contract

Wave energy tech developer Carnegie Clean Energy (ASX: CCE)  has been selected to receive a $6.3 million contract as part…

3 years ago

Schrole sees highest ever software contract sales in August, training division thrives as client portfolio broadens

Human resources (HR) Software-as-a-Service (SaaS) provider Schrole (ASX: SCL) has had a better August than some, as its portfolio expanded…

3 years ago

Director resigns, liquidation fear looms as Phoslock struggles to raise funds after China problems

In 2020, water treatment company Phoslock Environmental Technologies (ASX: PET) came under the scanner for accounting irregularities and fraud in…

3 years ago

INOVIQ teams up with ResearchDx for improved cancer biomarker detection

In 2023, the emerging cancer diagnostics market is estimated to be valued at over $23 billion. Everything is fair game…

3 years ago

Genetic Signatures lodges FDA application for rapid test kit to detect intestinal parasites

Gastrointestinal (GI) parasites are a pressing public health issue, affecting both humans and animals. Unfortunately, these diseases often go undiagnosed…

3 years ago

Mayne Pharma buys the global rights to rosacea treatment cream RHOFADE for $12.4m

In FY23, pharmaceutical company Mayne Pharma (ASX: MYX) reimagined its business to focus on dermatology and other core businesses. In…

3 years ago